Laurus Labs receives approvals from USFDA

11 Mar 2019 Evaluate

Laurus Labs has received a final approval from the United States Food and Drug Administration (USFDA) for Hydroxychloroquine Tablets 200 mg.

In another development, the Company also received a tentative approval for an ANDA for ADL (Abacavir, Dolutegravir, and Lamivudine) Tablets 600 mg/50 mg/300 mg from USFDA.

The products will be commercialized from Laurus' manufacturing site located at Atchutapuram, Visakhapatnam.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

605.95 19.15 (3.26%)
19-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1733.45
Dr. Reddys Lab 1171.90
Cipla 1498.50
Lupin 2060.70
Zydus Lifesciences 909.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...